Objectives To assess whether previous research on purported risk or protective factors for
Alzheimer's disease (AD) and cognitive decline is of sufficient strength to warrant specific …

NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive
decline. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …

Current research including the basic biology of Alzheimer's disease (AD) provides a
foundation to explore whether our current state of knowledge is sufficient to initiate …

Introduction Alzheimer's disease (AD) pathology, including the accumulation of amyloid beta
(Aβ) species and tau pathology, begins decades before the onset of cognitive impairment …

Background Numerous studies have investigated risk factors for Alzheimer disease (AD).
However, at a recent National Institutes of Health State-of-the-Science Conference, an …

There is increasing evidence that some lifestyle factors are linked to the development of
Alzheimer's disease. Many of these are potentially modifiable and include smoking, physical …

Alzheimer's disease (AD) affects more than 5 million Americans, with substantial
consequences for individuals with AD, families, and society in terms of morbidity, mortality …

The prevention of neurodegenerative dementias, such as Alzheimer disease, is a growing
public health concern, because of a lack of effective curative treatment options and a rising …

We describe events spanning over 20 years that have shaped our approach to identification
of interventions that may delay symptoms in Alzheimer's disease (AD). These events …

This review examines key pharmacological strategies that have been clinically studied for
the primary or secondary prevention of Alzheimer's disease. Much information …